Successful resolution of bowel obstruction in a patient with hereditary angioedema

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 6, 2008, Pages 583-587

  Zingale, Lorenza C ^a   Zanichelli, Andrea ^a   Deliliers, Daniela Lambertenghi ^a   Rondonotti, Emanuele ^a   De Franchis, Roberto ^b   Cicardi, Marco ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Abdominal attack; Capsule endoscopy; DX 88; Ecallantide; Edema; Kallikrein; Swelling

Indexed keywords

DANAZOL; DX 88; ECALLANTIDE; RECOMBINANT PROTEIN;

ABDOMINAL PAIN; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CAPSULE ENDOSCOPE; CASE REPORT; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; HUMAN; INTESTINE OBSTRUCTION; NAUSEA; PHAGE DISPLAY; PRIORITY JOURNAL;

AGED; ANGIOEDEMA, HEREDITARY; CAPSULE ENDOSCOPY; FEMALE; HUMANS; INTESTINAL OBSTRUCTION; KALLIKREINS; PEPTIDES;

EID: 43449112064     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f1c995     Document Type: Article

References (23)

1. Cicardi M, Agostoni A. Hereditary angioedema. N Engl J Med 1996; 334:1666-1667.
2. Osler W. Hereditary angioneurotic oedema. Am J Med Sci 1888; 95:362-367.
3. Crowder JR, Crowder TR. Five generations of angioneurotic edema. Arch Intern Med 1917; 20:840-852.
4. Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med 2001; 161:2417-2429.
5. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine 1992; 71:206-215.
6. Cicardi M, Bergamaschini L, Cugno M, Beretta A, Zingale LC, Colombo M, Agostoni A. Pathogenic and clinical aspects of C-1 inhibitor deficiency. Immunobiology 1998; 199:366-376.
7. Rosen FS, Charache P, Pensky J, Donaldson V. Hereditary angioneurotic edema: two genetic variants. Science 1965; 148:957-958.
8. Rosen FS, Alper CA, Pensky J, Klemperer MR, Donaldson VH. Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. J Clin Invest 1971; 50:2143-2149.
9. Davis AE III. The pathophysiology of hereditary angioedema. Clin Immunol 2005; 114:3-9.
10. Kunschak M, Engl W, Martisch F, Rosen FS, Eder G, Zerlauth G, Schwarz HP. A randomized, controlled trial to study the efficacy and safety of C1-INH concentrate in treating hereditary angioedema. Transfusion 1998; 38:540-549.
11. Bork K, Witzke G. Long-term prophylaxis with Cl-Inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired Cl-inhibitor deficiency. J Allergy Clin Immunol 1989; 83:677-682.
12. De Serres J, Groner A, Lindner J. Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinerts P) in hereditary angioedema: a review. Transfus Apheresis Sci 2003; 29:247-254.
13. Arreaza EE, Singh K, Grant JA. Hereditary angioedema: clinical and biochemical heterogeneity. Ann Allergy 1988; 61:69-74.
14. Sim TC, Grant JA. Hereditary angioedema: its diagnostic and management perspectives. Am J Med 1990; 88:656-664.
15. Greaves M, Lawlor F. Angioedema: manifestations and management. J Am Acad Dermatol 1991; 25 (1 pt 2):155-161.
16. Orfan NA, Kolske GB. Angioedema and C1-inhibitior deficiency. Ann Allergy 1992; 69:167-172.
17. Zurlo H, Frank MM. The long-term safety of danazol in women with hereditary angioedema. Fertil Steril 1990; 54:64-72.
18. Lumry W, Ritchie B, Beck T, Morrison J. Interim results of EDEMA2, a multicenter, open label, repeat-dosing study of intravenous and subcutaneous administration of ecallantide (DX-88) in hereditary angioedema. J Allergy Clin Immunol 2006; 117:S179.
19. Lehmann A. Ecallantide (dyax/genzyme). Curr Opin Investig Drugs 2006; 7:282-290.
20. Gonzales-Queved T, Caballero T, Cicardi M, Bork K, Williams A. The synthetic Kunitz domain protein DX88 to treat angioedema in patients with hereditary angioedema. Int Immunopharmacol 2002; 2:1318 (Abstract).
21. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet 1998; 351:1693-1697.
22. Han ED, MacFarlane RC, Mulligan AN, Scafidi J, Davis AE III. Increased vascular permeability in C1-INH-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest 2002; 109:1057-1063. Commentary, 1007-1009.
23. Williams A, Baird LG. DX-88 and HAE: a developmental perspective. Transfus Apheresis Sci 2003; 29:255-259.